DKA FINANS ApS: Financial statements 2019
CVR: 26028906
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
DKA FINANS ApS (CVR 26028906) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -292,940 compared with DKK -283,433 the year before. Equity in the 2019 report amounted to DKK -9,572,298.
- Profit/Loss
- DKK -292,940
- Equity
- DKK -9,572,298
- Total Assets
- DKK 572
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -293 t. | -9.6 mio. | - |
| 2018 | - | 0 | -283 t. | -9.3 mio. | - |
| 2017 | - | - | -266 t. | -9 mio. | - |
| 2016 | - | - | -2.3 mio. | -8.7 mio. | - |
| 2015 | - | -1 | -2.1 mio. | -47.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
DKA FINANS ApS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK -283,433.
About DKA FINANS ApS
DKA FINANS ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company has been dissolved on 25 September 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DKA PHARMA ApS and IMMUNOLEX THERAPEUTICS ApS. The company has 2 employees (2003). In 2024, the company reported a net result of DKK -140,083 compared with DKK -148,558 the year before. Equity in the 2024 report amounted to DKK -4,083,439.